ACRIX
Price
$28.43
Change
+$0.10 (+0.35%)
Updated
Jun 2 closing price
Net Assets
1.61B
CLTCX
Price
$16.47
Change
+$0.01 (+0.06%)
Updated
Jun 2 closing price
Net Assets
16.97M
Interact to see
Advertisement

ACRIX vs CLTCX

Header iconACRIX vs CLTCX Comparison
Open Charts ACRIX vs CLTCXBanner chart's image
ACRIX vs CLTCX Comparison Chart in %
View a ticker or compare two or three
VS
ACRIX vs. CLTCX commentary
Jun 03, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ACRIX is a StrongBuy and CLTCX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
ACRIX has more cash in the bank: 1.61B vs. CLTCX (17M). ACRIX pays higher dividends than CLTCX: ACRIX (0.67) vs CLTCX (0.00). ACRIX was incepted earlier than CLTCX: ACRIX (10 years) vs CLTCX (14 years). CLTCX (2.86) is less costly to investors than ACRIX (1.15). ACRIX is a more actively managed with annual turnover of: 172.00 vs. CLTCX (69.00). CLTCX has a lower initial minimum investment than ACRIX: CLTCX (2500) vs ACRIX (10000000). ACRIX annual gain was more profitable for investors over the last year : 17.01 vs. CLTCX (12.89). ACRIX return over 5 years is better than : 15.71 vs. CLTCX (-8.98).
ACRIXCLTCXACRIX / CLTCX
Total Expense Ratio1.152.2850%
Annual Report Gross Expense Ratio1.152.8640%
Fund Existence10 years14 years-
Gain YTD12.46510.842115%
Front LoadN/AN/A-
Min. Initial Investment100000002500400,000%
Min. Initial Investment IRAN/AN/A-
Net Assets1.61B17M9,447%
Annual Yield % from dividends0.670.00-
Returns for 1 year17.0112.89132%
Returns for 3 years36.3727.72131%
Returns for 5 years15.71-8.98-175%
Returns for 10 yearsN/A28.36-
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
TKR131.905.36
+4.24%
Timken Company (The)
GNS0.26N/A
+1.91%
Genius Group Limited
OXLCN24.940.22
+0.89%
Oxford Lane Capital Corp
VET11.730.08
+0.69%
Vermilion Energy
FBRX18.17-1.06
-5.54%
Forte Biosciences Inc